Long-term survival of hybrid total hip replacement for prior failed proximal femoral nail antirotation: a retrospective study with a median 10-year follow-up

• Published in: BMC musculoskeletal disorders Vol. 23; no. 1; pp. 1 - 868
• Main Authors: Wang, Lin, Yu, Minji, Zhang, Yaodong, Wang, Shuxin, Zhao, Mingdong, Yu, Mingliang, Li, Si, Gao, Songtao, Xiong, Min, Yu, Weiguang
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 16.09.2022; BioMed Central; BMC
• Subjects: Bone implants; Cement; Conversion; Failure; Femur; Fracture; Fractures; Hip; Musculoskeletal diseases; Orthopedics; Patients; Prostheses; Revision; Stress concentration; Survival; Total hip arthroplasty; Total hip replacement; Transplants & implants; China
• ISSN: 1471-2474; 1471-2474
• DOI: 10.1186/s12891-022-05827-3

Abstract Background Hybrid total hip replacement (THR) is commonly used in the management of proximal femur fractures in elderly individuals. However, in the context of the revision, the literature on hybrid THR is limited, and differences in the long-term survival outcomes reported in the literature are obvious. This retrospective study aimed to evaluate the long-term survival of hybrid THR for failed proximal femoral nail antirotation (PFNA) in elderly individuals aged ≥ 75 years. Methods An observational cohort of 227 consecutive individuals aged ≥ 75 years who experienced hybrid THRs following prior primary PFNAs was retrospectively identified from the Joint Surgery Centre, the First Affiliated Hospital, Sun Yat-sen University. Implant survival was estimated using the Kaplan–Meier method. The primary end point was the implant survivorship calculated using the Kaplan–Meier method with revision for any reason as the end point; secondary end points were the function score measured using the modified Harris Hip Score (mHHS) and the incidence of main orthopaedic complications. Results In total, 118 individuals (118 THRs) were assessed as available. The median follow-up was 10 (3–11) years. The 10-year survivorship with revision for any reason as the endpoint was 0.914 (95% confidence interval [CI], 0.843–0.960). The most common indication for revision was aseptic loosening (70.0%), followed by periprosthetic fracture (30.0%). At the final follow-up, the median functional score was 83.6 (79.0–94.0). Among the 118 patients included in this study, 16 experienced 26 implant-related complications. The overall incidence of key orthopaedic complications was 13.5% (16/118). Conclusion For patients aged ≥ 75 years old with prior failed PFNAs, hybrid THR may yield satisfactory long-term survival, with good functional outcomes and a low rate of key orthopaedic complications.